Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
BMJ Open|November 4, 2015
Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literatureBeverley M Shields, Jaime L Peters, Chris Cooper, et al.
BMJ Open Sport & Exercise Medicine|April 8, 2025
Can 4 weeks of real-world active breaks improve glycaemic management in sedentary adults with type 1 diabetes? The EXTOD-Active randomised control trial protocolJoseph G Jenkins, Matthew Cocks, Parth Narendran, et al.
International Journal of Epidemiology|December 21, 2020
Investigating the causal effect of maternal vitamin B12 and folate levels on offspring birthweightGunn-Helen Moen, Robin N Beaumont, Niels Grarup, et al.
Diabetologia|October 15, 2013
The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cellsRichard A Oram, Angus G Jones, Rachel E J Besser, et al.
Pediatrics|August 20, 2016
Prematurity and Genetic Testing for Neonatal DiabetesRachel E J Besser, Sarah E Flanagan, Deborah G J Mackay, et al.
Diabetes, Obesity & Metabolism|May 16, 2025
Evaluating prediction of short-term tolerability of five type 2 diabetes drug classes using routine clinical features: UK population-based studyPedro Cardoso, Katie G Young, Rhian Hopkins, et al.
European Journal of Endocrinology|October 11, 2021
Birth weight and diazoxide unresponsiveness strongly predict the likelihood of congenital hyperinsulinism due to a mutation in ABCC8 or KCNJ11Thomas I Hewat, Daphne Yau, Joseph C S Jerome, et al.
Diabetes Care|June 9, 2018
C-Peptide Decline in Type 1 Diabetes Has Two Phases: An Initial Exponential Fall and a Subsequent Stable PhaseBeverley M Shields, Timothy J McDonald, Richard Oram, et al.
Diabetes Care|October 7, 2022
Routine Islet Autoantibody Testing in Clinically Diagnosed Adult-Onset Type 1 Diabetes Can Help Identify Misclassification and the Possibility of Successful Insulin CessationRussell J Eason, Nicholas J Thomas, Anita V Hill, et al.
BMJ Open Diabetes Research & Care|May 26, 2020
Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuationAndrew P McGovern, Michael Hogg, Beverley M Shields, et al.
Pageof 12